Apogee Therapeutics, Inc. APGE Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s operating lease liabilities?
- Apogee Therapeutics, Inc. (APGE) reported operating lease liabilities of -$802K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s operating lease liabilities increased by 20.9% year-over-year, from -$1.01M to -$802K.
- What is the long-term trend for Apogee Therapeutics, Inc.'s operating lease liabilities?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s operating lease liabilities has grown at a 284.0% compound annual growth rate (CAGR), from -$270K to -$3.98M.